FDA New Strategy To Replace Animal Testing: The Future of Drug Development is Human-Centered and Tech-Driven

In a groundbreaking move towards more ethical and efficient drug development, the U.S. Food and Drug Administration (FDA) has announced a significant shift away from animal testing in the creation of monoclonal antibody therapies and other medications. This bold strategy promises to revolutionize how drugs are developed, evaluated, and brought to market, marking a new era where human-relevant methods take the lead.